ESLOF

Healthcare

EssilorLuxottica S.A. · Medical - Instruments & Supplies · $93B

UQS Score — Balanced Preset
49.9
Below Average

EssilorLuxottica S.A. scores 49.9/100 using the Balanced preset.

UQS vs Healthcare Sector
ESLOF
49.9
Sector avg
32.4
Quality
Neutral
Moat
Neutral
Growth
Neutral
Risk
Neutral
Valuation
Good

What is EssilorLuxottica S.A.?

EssilorLuxottica is a global leader in eyewear, combining ophthalmic lens technology with iconic frame and sunglass brands. Headquartered in Paris, the company serves consumers and eye care professionals across six continents.

EssilorLuxottica designs, manufactures, and distributes corrective lenses, frames, and sunglasses through wholesale and retail channels worldwide. Revenue flows from lens technology brands, luxury and sports eyewear, optical equipment sold to laboratories, and non-prescription sunglasses and readers sold through mass-market channels.

The company was formed in 2010 and is headquartered in Paris, France.

  • Progressive and photochromic corrective lenses (Varilux, Transitions, Crizal)
  • Luxury and sports eyewear wholesale and retail
  • Optical and surfacing equipment for prescription laboratories
  • Non-prescription sunglasses and readers (Foster Grant, Magnivision)

Is ESLOF a Good Stock to Buy?

UQS Score rates ESLOF as Below Average overall.

Valuation stands out as the most favorable pillar, suggesting the stock is not expensively priced relative to its fundamentals. Moat, Growth, and Risk each sit at a Neutral level, reflecting a stable but unexceptional competitive and financial profile.

The Quality pillar registers as Weak, pointing to underlying profitability or capital-efficiency concerns that weigh on the composite score.

See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →

Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.

Does ESLOF pay dividends?

Yes — EssilorLuxottica S.A. pays a dividend.

EssilorLuxottica pays a regular dividend, which may appeal to income-oriented investors. As a large, globally diversified eyewear company, returning cash to shareholders through dividends reflects its established market position and relatively stable cash generation.

When does ESLOF report earnings?

EssilorLuxottica reports earnings on a regular cadence, typical for large-cap European-listed equities.

The company's Neutral Growth and Risk pillar ratings suggest steady but unspectacular recent results, without major positive or negative surprises standing out in the UQS framework.

For the most recent quarter's results, visit EssilorLuxottica's investor relations page directly.

ESLOF Price History

+49.0% over 5Y

Monthly close, adjusted for stock splits and dividend reinvestment.

Return Calculator

What if I invested in EssilorLuxottica S.A.?

$
Today it would be worth
$15,699
That's a +57.0% total return, or +9.4% annualized.

Based on EssilorLuxottica S.A.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.

Frequently Asked Questions

What does EssilorLuxottica do?

EssilorLuxottica designs, manufactures, and sells ophthalmic lenses, eyeglass frames, and sunglasses globally. It operates across wholesale, retail, lens technology, optical equipment, and non-prescription eyewear segments, serving both consumers and eye care professionals.

Does ESLOF pay dividends?

Yes, EssilorLuxottica pays a regular dividend. Income-focused investors should check the company's investor relations page for the current dividend amount and payment schedule, as specific dates are not covered by our data source.

When does ESLOF report earnings?

EssilorLuxottica follows a regular reporting cadence standard for large-cap equities. For precise upcoming earnings dates, refer to the company's official investor relations page.

Is ESLOF a good stock to buy?

UQS Score rates ESLOF as Below Average, driven primarily by a Weak Quality pillar. While Valuation is rated Good and several other pillars are Neutral, the overall profile suggests caution. Pro members can view the complete breakdown to form their own judgment.

Is ESLOF overvalued?

The UQS Valuation pillar for ESLOF is rated Good, indicating the stock does not appear expensively priced relative to its fundamentals. However, valuation alone does not determine overall quality — the full UQS composite remains Below Average.

What is ESLOF's market cap bracket?

EssilorLuxottica is classified as a large-cap company, reflecting its scale as one of the world's dominant eyewear groups with operations across North America, Europe, Asia, and beyond.

Is ESLOF a long-term quality investment?

As a long-term quality indicator, UQS rates ESLOF Below Average. The Weak Quality pillar is a meaningful concern for long-term holders, though the Neutral Moat and Risk ratings suggest the business is not in acute distress. Pro members can explore the full pillar detail.

What sector does ESLOF belong to?

EssilorLuxottica is classified in the Healthcare sector, specifically within medical devices and optical products. Its business spans both consumer eyewear and professional optical instruments, giving it exposure to both healthcare and consumer spending trends.

Unlock Full ESLOF Analysis

Sign in to unlock the detailed analysis behind the UQS Score.

  • View the exact UQS pillar scores across Quality, Moat, Growth, Risk, and Valuation
  • Access full financial metrics and capital-efficiency indicators
  • Compare ESLOF against sector peers on a standardized scoring framework
  • Get the complete analyst view available to Pro members
Analyze ESLOF in Detail →

Pro Analysis

ESLOF — Score History

4045505560Apr 5Apr 15Apr 25May 5May 15May 24v5
Score changes· 20 most recent
DateUQSQualityMoatGrowthRiskValueChange
May 22, 202649.841.351.047.752.762.0-0.1
May 19, 202649.941.351.047.852.762.2-0.6
May 13, 202650.541.851.048.952.763.9+0.9
May 7, 202649.640.851.048.652.760.5-0.2
May 5, 202649.840.851.048.652.761.5+0.1
May 1, 202649.740.851.048.052.761.40.0
Apr 27, 202649.740.851.048.152.761.5-0.6
Apr 25, 202650.340.851.050.652.761.9+0.4
Apr 23, 202649.940.051.050.652.760.80.0
Apr 21, 202649.939.851.050.752.761.2+0.2

ESLOF — Pillar Breakdown

Quality

41.4/100 (25%)

EssilorLuxottica S.A. has average quality metrics, with room for improvement in margins or capital efficiency.

Capital Efficiency (ROIC)Weak

How effectively capital is deployed to generate returns.

Return on EquityWeak

Profitability relative to shareholders' equity.

Operating ProfitabilityWeak

Ability to convert revenue into operating profit.

Net ProfitabilityModerate

Bottom-line profit as a share of revenue.

Gross Profit / AssetsModerate

Asset productivity — how much gross profit each dollar of assets generates.

Cash GenerationModerate

Free cash flow relative to market value.

Growth

47.3/100 (20%)

EssilorLuxottica S.A. shows steady but unspectacular growth, typical for mature companies.

Recent Revenue TrendWeak

Revenue trajectory over the last twelve months.

3Y Revenue CAGRWeak

Compound annual revenue growth rate over 3 years.

EPS GrowthWeak

Year-over-year earnings per share growth.

Forward Revenue OutlookModerate

Analyst consensus for future revenue growth.

Forward EPS GrowthStrong

Analyst consensus for future earnings growth.

Risk

52.7/100 (15%)

EssilorLuxottica S.A. has some risk factors including moderate leverage or solvency concerns.

Financial LeverageWeak

Debt levels relative to earnings capacity.

Debt/EquityStrong

Total debt relative to shareholder equity.

Current RatioWeak

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageStrong

Earnings capacity relative to interest payments.

Valuation

62.7/100 (15%)

EssilorLuxottica S.A. trades at a reasonable valuation with decent earnings yield and FCF multiples.

Earnings YieldModerate

Inverse of forward P/E — higher yield means cheaper stock.

Price to Free Cash FlowStrong

How many years of FCF the market cap represents.

PEG RatioStrong

P/E relative to earnings growth — lower is more attractive.

EV/EBITDA vs SectorWeak

Enterprise value multiple relative to sector median.

Moat

51/100 (25%)

EssilorLuxottica S.A. possesses some competitive advantages but faces meaningful competition. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for ESLOF.

Score Composition

Quality
41.4×25%10.3
Growth
47.3×20%9.5
Risk
52.7×15%7.9
Valuation
62.7×15%9.4
Moat
51.0×25%12.8
Total
49.9Below Average

Financial Data

More Stock Analysis

How is the ESLOF UQS Score Calculated?

The UQS (Unified Quality Score) for EssilorLuxottica S.A. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses EssilorLuxottica S.A.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether EssilorLuxottica S.A. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.